SERF1B

gene
On this page

Also known as FAM2BH4F5C

Summary

SERF1B (small EDRK-rich factor 1B, HGNC:10756) is a protein-coding gene on chromosome 5q13.2, encoding Small EDRK-rich factor 1 (O75920). Positive regulator of amyloid protein aggregation and proteotoxicity.

This gene is part of a 500 kb inverted duplication on chromosome 5q13. This duplicated region contains at least four genes and repetitive elements which make it prone to rearrangements and deletions. The repetitiveness and complexity of the sequence have also caused difficulty in determining the organization of this genomic region. This gene is the centromeric copy which is identical to the telomeric copy. Alternatively spliced transcripts have been documented but it is unclear whether alternative splicing occurs for both the centromeric and telomeric copies of the gene. The gene encodes a protein of unknown function which bears low-level homology with the RNA-binding domain of matrin-cyclophilin, a protein which colocalizes with small nuclear ribonucleoproteins (snRNPs) and the SMN1 gene product.

Source: NCBI Gene 728492 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 2 total
  • MANE Select transcript: NM_022978

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:10756
Approved symbolSERF1B
Namesmall EDRK-rich factor 1B
Location5q13.2
Locus typegene with protein product
StatusApproved
AliasesFAM2B, H4F5C
Ensembl geneENSG00000205572
Ensembl biotypeprotein_coding
Entrez728492

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 5 protein_coding, 2 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000380750, ENST00000380751, ENST00000503931, ENST00000506542, ENST00000507177, ENST00000513144, ENST00000514285, ENST00000515588

RefSeq mRNA: 2 — MANE Select: NM_022978 NM_001178087, NM_022978

CCDS: CCDS43326, CCDS54866

Canonical transcript exons

ENST00000380750 — 3 exons

ExonStartEnd
ENSE000020735737002525170025458
ENSE000020792137004152470043113
ENSE000034627127002640770026515

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 92.75.

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
prefrontal cortexUBERON:000045192.75gold quality
cortical plateUBERON:000534391.62gold quality
frontal cortexUBERON:000187090.95gold quality
dorsolateral prefrontal cortexUBERON:000983490.33gold quality
left testisUBERON:000453390.32gold quality
Brodmann (1909) area 9UBERON:001354090.11gold quality
cerebral cortexUBERON:000095689.95gold quality
anterior cingulate cortexUBERON:000983589.66gold quality
testisUBERON:000047389.58gold quality
mucosa of transverse colonUBERON:000499189.44gold quality
putamenUBERON:000187489.24gold quality
right testisUBERON:000453488.79gold quality
nucleus accumbensUBERON:000188288.72gold quality
primary visual cortexUBERON:000243688.72gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047388.64gold quality
hypothalamusUBERON:000189888.58gold quality
brainUBERON:000095588.52gold quality
ganglionic eminenceUBERON:000402388.52gold quality
superior frontal gyrusUBERON:000266188.49gold quality
right frontal lobeUBERON:000281088.33gold quality
caudate nucleusUBERON:000187387.96gold quality
cerebellar hemisphereUBERON:000224587.88gold quality
cerebellar cortexUBERON:000212987.86gold quality
cerebellumUBERON:000203787.85gold quality
right hemisphere of cerebellumUBERON:001489087.64gold quality
substantia nigraUBERON:000203887.58gold quality
Ammon’s hornUBERON:000195487.05gold quality
ventricular zoneUBERON:000305386.97gold quality
temporal lobeUBERON:000187186.88gold quality
amygdalaUBERON:000187686.86gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-GEOD-134144yes29.13
E-MTAB-6524no142.22
E-MTAB-7316no36.66
E-ANND-3no0.61

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

56 targeting SERF1B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-450A-1-3P100.0069.331837
HSA-MIR-4455100.0065.481587
HSA-MIR-126-5P100.0072.713180
HSA-MIR-513A-5P100.0069.772465
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-302E99.9670.742669
HSA-MIR-6508-5P99.9270.672465
HSA-MIR-106A-5P99.9073.942683
HSA-MIR-302A-3P99.8971.231777
HSA-MIR-302B-3P99.8971.231777
HSA-MIR-302C-3P99.8971.201778
HSA-MIR-302D-3P99.8971.251777
HSA-MIR-17-5P99.8973.832665
HSA-MIR-106B-5P99.8874.722795
HSA-MIR-20A-5P99.8874.762769
HSA-MIR-20B-5P99.8874.012621
HSA-MIR-519D-3P99.8873.972607
HSA-MIR-93-5P99.8873.982606
HSA-MIR-526B-3P99.8874.062587
HSA-MIR-806799.8669.592260
HSA-MIR-373-3P99.8470.681668
HSA-MIR-520E-3P99.8470.551698
HSA-MIR-372-3P99.8370.581691
HSA-MIR-520A-3P99.8370.591687
HSA-MIR-520B-3P99.8370.561699
HSA-MIR-520C-3P99.8370.561699
HSA-MIR-520D-3P99.8370.781676

Cross-species orthologs

0 orthologs

Paralogs (1): SERF1A (ENSG00000172058)

Protein

Protein identifiers

Small EDRK-rich factor 1O75920 (reviewed: O75920)

Alternative names: Protein 4F5, SMA modifier 1

All UniProt accessions (4): D6RC42, D6RC90, D6RCL9, O75920

UniProt curated annotations — full annotation on UniProt →

Function. Positive regulator of amyloid protein aggregation and proteotoxicity. Induces conformational changes in amyloid proteins, such as APP, HTT, and SNCA, driving them into compact formations preceding the formation of aggregates.

Subunit / interactions. Interacts with SNCA; this interaction promotes the aggregation of SNCA.

Subcellular location. Cytoplasm. Cytosol. Nucleus.

Tissue specificity. Isoform Long is predominantly expressed in heart, brain and skeletal muscle. Isoform Short and Isoform Long are expressed throughout the central nervous system, including spinal cord.

Similarity. Belongs to the SERF family.

Isoforms (2)

UniProt IDNamesCanonical?
O75920-1Longyes
O75920-2Short

RefSeq proteins (2): NP_001171558, NP_075267* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR007513SERF-like_NDomain
IPR040211SERF1/2-likeFamily

Pfam: PF04419

UniProt features (17 total): mutagenesis site 11, region of interest 2, compositionally biased region 2, chain 1, splice variant 1

Structure

Experimental structures (PDB)

2 structures.

PDBMethodResolution (Å)
9M27SOLUTION NMR
9M2DSOLUTION NMR

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-O75920-F163.770.00

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Mutagenesis-validated functional residues (11):

PositionPhenotype
13inhibits snca binding.
14decreases snca binding.
16drastically decreases snca binding.
16inhibits snca binding.
17drastically decreases snca binding.
17inhibits snca binding.
18no effect on snca binding.
11no effect on snca binding.
11decreases snca binding.
12slightly decreases snca binding.
13decreases snca binding.

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 36 (showing top): GOBP_PROTEIN_DESTABILIZATION, GOBP_REGULATION_OF_PROTEIN_STABILITY, DANG_BOUND_BY_MYC, BENPORATH_MYC_MAX_TARGETS, GOBP_SUPRAMOLECULAR_FIBER_ORGANIZATION, FORTSCHEGGER_PHF8_TARGETS_UP, GOBP_AMYLOID_FIBRIL_FORMATION, MIR616_5P, MIR371B_5P, MIR373_5P, MIR106B_5P, MIR20A_5P, MIR106A_5P, MIR17_5P, MIR561_3P

GO Biological Process (3): nervous system development (GO:0007399), protein destabilization (GO:0031648), amyloid fibril formation (GO:1990000)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (5): nucleus (GO:0005634), cytosol (GO:0005829), protein-containing complex (GO:0032991), cytoplasm (GO:0005737), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
system development1
regulation of protein stability1
protein metabolic process1
supramolecular fiber organization1
binding1
intracellular membrane-bounded organelle1
cytoplasm1
cellular_component1
intracellular anatomical structure1

Protein interactions and networks

STRING

380 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SERF1BNDUFAF3Q9BU61919
SERF1BNAIPQ13075872
SERF1BSMN1Q16637839
SERF1BGPKOWQ92917724
SERF1BC1SP09871720
SERF1BBDP1A6H8Y1688
SERF1BTAAR8Q969N4605
SERF1BGTF2H2Q13888599
SERF1BTPMTP51580592
SERF1BGTF2H2CQ6P1K8583
SERF1BCD82P27701582
SERF1BTAAR6Q96RI8517
SERF1BBACE1P56817507
SERF1BPLS3P13797491
SERF1BZNF77Q15935479

IntAct

44 interactions, top by confidence:

ABTypeScore
MED4MED19psi-mi:“MI:0914”(association)0.900
SERF1ATIMMDC1psi-mi:“MI:0915”(physical association)0.560
SERF1ACERS4psi-mi:“MI:0915”(physical association)0.560
SERF1AELOVL7psi-mi:“MI:0915”(physical association)0.560
SERF1AAQP6psi-mi:“MI:0915”(physical association)0.560
SERF1AREEP4psi-mi:“MI:0915”(physical association)0.560
ELOVL7SERF1Apsi-mi:“MI:0915”(physical association)0.560
SERF1ATMX2psi-mi:“MI:0915”(physical association)0.560
SERF1ATMEM14Bpsi-mi:“MI:0915”(physical association)0.560
SERF1ACRB3psi-mi:“MI:0915”(physical association)0.560
SERF1AABHD16Apsi-mi:“MI:0915”(physical association)0.560
SERF1ARNASEKpsi-mi:“MI:0915”(physical association)0.560
SERF1AELOVL4psi-mi:“MI:0915”(physical association)0.560
SERF1AGPR152psi-mi:“MI:0915”(physical association)0.560
SERF1ALRRK2psi-mi:“MI:0407”(direct interaction)0.440
SERF1ASRPK2psi-mi:“MI:0217”(phosphorylation reaction)0.440
SRPK1SERF1Apsi-mi:“MI:0217”(phosphorylation reaction)0.440
SERF1ASMC2psi-mi:“MI:0914”(association)0.350
PIK3R3SERF1Apsi-mi:“MI:0915”(physical association)0.000
SERF1ATMX2psi-mi:“MI:0915”(physical association)0.000
SERF1ATMEM14Bpsi-mi:“MI:0915”(physical association)0.000
SERF1ACRB3psi-mi:“MI:0915”(physical association)0.000

BioGRID (33): SERF1A (Affinity Capture-MS), SERF1A (Reconstituted Complex), SERF1A (Affinity Capture-RNA), SERF1A (Two-hybrid), SERF1B (Two-hybrid), SERF1A (Two-hybrid), SERF1B (Two-hybrid), SERF1A (Two-hybrid), SERF1B (Two-hybrid), SERF1A (Two-hybrid), SERF1B (Two-hybrid), SERF1A (Two-hybrid), SERF1B (Two-hybrid), SERF1A (Two-hybrid), SERF1B (Two-hybrid)

ESM2 similar proteins: A6NC05, O13533, O13579, O71190, O75920, P0DM64, P0DO27, P12913, P38161, P38808, P38864, P43151, P47126, P53105, P53908, P76163, Q04502, Q08927, Q12169, Q12307, Q13536, Q16612, Q3E751, Q3Y452, Q495C1, Q4R541, Q53S99, Q5NVD3, Q69UP7, Q6B0X1, Q6DN03, Q6Q5F3, Q6Z2K1, Q6ZS49, Q6ZS62, Q6ZS92, Q70YC4, Q8BCV4, Q8FIP8, Q8N0U6

Diamond homologs: A5JSS4, B1MTI8, O75920, O88892, P84101, P84102, Q32P76, Q5R7C4, Q9BKU8, Q9VEW2, Q3E7B7

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

2 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

607 predictions. Top by Δscore:

VariantEffectΔscore
5:70026513:GAG:Gdonor_gain1.0000
5:70026516:GT:Gdonor_loss1.0000
5:70025374:T:TAdonor_gain0.9900
5:70025375:G:GAdonor_gain0.9900
5:70025379:ACG:Adonor_gain0.9900
5:70025434:GC:Gdonor_gain0.9900
5:70025444:T:TAdonor_gain0.9900
5:70025445:G:GAdonor_gain0.9900
5:70025459:G:GGdonor_gain0.9900
5:70026405:A:ACacceptor_loss0.9900
5:70026406:GGT:Gacceptor_gain0.9900
5:70026516:G:GGdonor_gain0.9900
5:70032310:TGTA:Tacceptor_loss0.9900
5:70032311:GTA:Gacceptor_loss0.9900
5:70032312:TA:Tacceptor_loss0.9900
5:70032313:A:AGacceptor_gain0.9900
5:70032313:A:Tacceptor_loss0.9900
5:70032313:AG:Aacceptor_gain0.9900
5:70032314:G:GGacceptor_gain0.9900
5:70032314:GG:Gacceptor_gain0.9900
5:70025454:GGCCC:Gdonor_gain0.9800
5:70025455:GCCC:Gdonor_gain0.9800
5:70025455:GCCCG:Gdonor_gain0.9800
5:70026405:A:AGacceptor_gain0.9800
5:70026405:AGGT:Aacceptor_gain0.9800
5:70026406:G:GGacceptor_gain0.9800
5:70026406:GGTG:Gacceptor_gain0.9800
5:70032313:AGG:Aacceptor_gain0.9800
5:70032314:GGG:Gacceptor_gain0.9800
5:70032314:GGGA:Gacceptor_gain0.9800

AlphaMissense

725 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1003334033 (5:70028432 A>C), RS1004741285 (5:70036325 G>A), RS1004795241 (5:70032255 C>G), RS1010920459 (5:70037914 C>G), RS1011434092 (5:70036547 A>G,T), RS1012427821 (5:70041082 G>A), RS1012787687 (5:70043498 T>G), RS1013763284 (5:70031507 G>A), RS1015527914 (5:70032348 A>G), RS1015581845 (5:70029535 C>T), RS1022448670 (5:70036901 A>G), RS1023284941 (5:70038139 G>C), RS1024281922 (5:70041089 C>T), RS1027549024 (5:70029284 C>A,T), RS1027908605 (5:70032130 T>C)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

12 total (human), top 12 by PubMed support.

ChemicalActions (top 5)PubMed papers
Aflatoxin B1decreases methylation, increases expression2
aristolochic acid Iincreases expression1
CGP 52608affects binding, increases reaction1
chloropicrinincreases expression1
ICG 001decreases expression1
Grape Seed Proanthocyanidinsaffects cotreatment, increases expression1
theaflavin-3,3’-digallateaffects expression1
Benzo(a)pyreneincreases expression1
Catechinaffects cotreatment, increases expression1
Smokedecreases expression1
Valproic Aciddecreases methylation1
Sodium Seleniteincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.